Pharma Industry Engagement in aLI 2025
analytica Lab India 2025 witnessed unprecedented engagement from Hyderabad’s pharmaceutical ecosystem, which represents India’s most concentrated pharma hub with over ₹90,000 crore Pharma Vision driving the state’s biotechnology and pharmaceutical manufacturing expansion. The expo strategically positioned itself at the heart of Telangana’s pharmaceutical corridor, home to industry giants including:
Aurobindo Pharma– Represented through Madan Mohan Reddy, Whole Time Director, who served as the Guest of Honour at the inauguration ceremony, underscoring the company’s commitment to advancing laboratory technology adoption. As India’s first pharmaceutical company listed on NYSE and holding leadership positions in ANDA approvals from USFDA, Dr. Reddy’s participation emphasized the criticality of cutting-edge analytical instrumentation for maintaining regulatory compliance across global markets.
Aurobindo Pharma – A key participant representing one of the top 5 Indian companies in terms of ANDA filings, showcasing their focus on advanced analytical technologies essential for maintaining their position as a leading supplier to regulated markets including North America and European Union.
Gland Chemicals – Featured through B.N. Malleswara Rao, Managing Director, as a Special Guest at the inauguration, representing the company’s expertise in specialty chemical manufacturing and active pharmaceutical ingredients, highlighting the integration between chemical synthesis and analytical validation.
The expo facilitated high-level strategic discussions through the presence of senior pharmaceutical executives who participated in procurement planning sessions, technology roadshows, and strategic partnership meetings:
Laurus Labs – Girish Kottapalli, VP-Operations, emphasized the expo’s comprehensive coverage spanning “API to formulation, biotechnology, and analytics,” positioning it as essential for both domestic and international pharmaceutical market development.
Mankind Pharma – Abhay Srivastava, President Operations, highlighted the strategic importance of Hyderabad as “the perfect location” for pharmaceutical technology convergence, emphasizing the city’s role as a hub of progress and innovation not only for India but globally.
Procurement Activities & Tech Adoption Strategies
The Hosted Buyer Program emerged as a cornerstone of pharmaceutical industry engagement, facilitating structured procurement activities through:
250+ Hosted Buyer meetings with qualified pharmaceutical executives from leading companies, including pre-scheduled one-on-one sessions between technology providers and pharmaceutical decision-makers. The program attracted participants from:
- KDPMA (Karnataka Drug and Pharmaceutical Manufacturers Association)
- IDMA Gujarat and Tamil Nadu chapters
- MPSDMA (Madhya Pradesh State Drug Manufacturers Association)
- APPON Nepal (Association of Pharmaceutical Producers of Nepal)
Domestic pharmaceutical buyers from Delhi, Guwahati, Kolkata, Bangalore, Chennai, Indore, Goa, and Ahmedabad participated alongside international buyers from Egypt, South Africa, Nepal, Libya, Bangladesh, Ghana, Jordan, and Kenya.
Pharmaceutical companies demonstrated focused procurement strategies across multiple technology categories:
Laboratory Automation: Companies like Dr. Reddy’s and Aurobindo engaged with SVAN Analytical Instruments for DENSO Cobotta Pro robotic systems, Glatt’s lights-off production technologies, and AAtek Group’s collaborative robotics solutions for API manufacturing and quality control laboratories
Analytical Instrumentation: Shimadzu’s 150th anniversary portfolio featuring craft-tech GC and HPLC systems attracted significant interest from pharmaceutical QC departments seeking to upgrade legacy analytical capabilities with advanced precision instrumentation.
Sustainable Manufacturing: SpinChem’s Rotating Bed Reactor technology secured its first major production-scale order from Indian pharmaceutical companies during the expo, with four of India’s top pharmaceutical companies including Dr. Reddy’s, Aurobindo, and Lupin advancing from laboratory-scale trials to commercial deployment.
Pharmaceutical companies prioritized digital laboratory solutions, evidenced by significant engagement with:
Thru’s Manufacturing Execution Systems and AI-driven decision-making platforms for real-time production control and automated quality management.
Dhruvsoft-Zoho partnerships for HIPAA, ISO, and GDPR-compliant cloud platforms enabling R&D management, compliance readiness, inventory automation, and clinical workflows.
Mettler-Toledo’s integrated analytical solutions featuring CFR Part 21 compliance and real-time regulatory audit capabilities addressing pharmaceutical companies’ increasing demands for data integrity frameworks.
Conference-Driven Networking
The three-day conference program facilitated strategic networking through industry-specific sessions:
Day 1: “The Intelligent Lab: Driving Productivity with Automation and Compliance” – Collaboration between Indian Analytical Instruments Association (IAIA) and MesseMünchen India.
Day 2: Dual-track sessions on “Innovating Science: Advancing Analytics for a Sustainable Future” and “Shaping Pharma 2030: Resilience, Robotics, and Revolution” in partnership with Indian Pharmaceutical Alliance (IPA).
Day 3: “The Analytics Advantage: Ensuring Quality, Safety, and Regulatory Excellence” – Collaboration with The Society of Clinical Research and Medical Professionals (SCRMP).
The Career Connect Initiative in partnership with FABA (Federation of Asian Biotech Associations) connected pharmaceutical companies with over 400+ leading life science employers, facilitating recruitment drives and talent acquisition for emerging pharmaceutical technologies.
Hyderabad as India’s Pharma Hub
Hyderabad’s pharmaceutical ecosystem demonstrated its global competitiveness through several key metrics showcased during the expo:
FDA Approvals: Telangana remains the only region globally with over 200 FDA-approved pharmaceutical manufacturing sites, representing the highest concentration of regulated manufacturing facilities outside the United States.
Biologics Leadership: The city leads India’s biological production through key players including Dr. Reddy’s Laboratories, Biological E, Bharat Biotech, and Aurobindo, collectively representing India’s emergence as the biologics capital of the world.
Export Excellence: Over 60% of revenues from Hyderabad-based pharmaceutical companies are generated from export markets, with major revenues from regulated US and EU markets, positioning the city as a critical node in global pharmaceutical supply chains.
Pharmaceutical companies in Hyderabad leveraged the expo to advance Industry 4.0 implementation through:
IoT Asset Tracking: Leading biopharmaceutical companies deployed IoT-based asset tracking systems for equipment management, compliance monitoring, and predictive maintenance across manufacturing and laboratory operations.
Smart Manufacturing: Integration of IIoT sensors, Big Data analytics, predictive analytics, and cloud computing to enhance R&D, manufacturing, and regulatory compliance capabilities.
Digital Laboratory Solutions: Adoption of LIMS, ELN, and QMS platforms ensuring CFR Part 11 compliance while enabling real-time data integration across pharmaceutical value chains.
Global Lab Equipment Integration
Pharmaceutical companies established multiple bilateral technology partnerships during the expo:
German Technology Integration: Partnerships with Mettler-Toledo for precision analytical balances, OPTIMA for AI-driven filling systems, and Glatt for automated production technologies created comprehensive technology ecosystems.
Japanese Precision Manufacturing: Shimadzu’s craft-tech analytical systems enabled pharmaceutical companies to access 150 years of analytical expertise combined with traditional Japanese craftsmanship for enhanced precision and reliability.
Swedish Process Innovation: SpinChem’s market breakthrough demonstrated successful Sweden-India collaboration in sustainable pharmaceutical manufacturing, with their Rotating Bed Reactor technology addressing critical pharmaceutical process challenges.
Global service providers established comprehensive support networks for Indian pharmaceutical companies:
Spinco Group leveraged their position as Shimadzu’s best distributor to provide technology transfer, application development, and regulatory support services for pharmaceutical analytical laboratories.
AAtek Group’s partnership with Tata Elxsi and DENSO Robotics Europe created the “Robotics and Automation Innovation Lab” in Frankfurt, providing Indian pharmaceutical companies with access to European automation expertise.
The expo generated substantial immediate procurement outcomes:
Over 1,500 buyer-seller meetings resulted in confirmed technology purchases exceeding €50 million across laboratory automation, analytical instrumentation, and pharmaceutical manufacturing equipment.
120+ product launches created new procurement opportunities for pharmaceutical companies seeking cutting-edge technologies for competitive advantage.
Digital transformation partnerships established through Dhruvsoft-Zoho collaborations enabled pharmaceutical companies to implement HIPAA, ISO, and GDPR-compliant cloud platforms.
Pharmaceutical companies established long-term strategic partnerships including:
Joint Development Agreements between Indian pharmaceutical manufacturers and international technology providers for customized analytical solutions and process automation systems.
Technology Licensing Partnerships enabling Indian companies to access patented analytical technologies while contributing local manufacturing and application expertise.
Co-Manufacturing Arrangements spanning oncology, biologics, and advanced drug delivery systems, facilitated through expo networking and technology demonstrations.
Pharmaceutical companies achieved significant regulatory compliance enhancements through:
CFR Part 11 Compliance Implementation: Digital laboratory solutions enabling real-time audit readiness and automated data integrity protocols.
Annex 1 Compatibility: Cleanroom and containment technologies ensuring European regulatory compliance for pharmaceutical exports.Innovation-Guide-2025-Analytica.pdf
ISO Certification Frameworks: Comprehensive quality management systems supporting global pharmaceutical market access requirements.
The pharmaceutical industry engagement at analytica Lab India 2025 demonstrated Hyderabad’s position as India’s pharmaceutical capital while facilitating comprehensive technology adoption, strategic partnerships, and procurement activities that will drive the industry’s transformation toward Pharma 4.0 implementation and global competitive excellence.Raja Aditya
